COVID-19: EU to buy up to 300million doses of BioNTech-Pfizer’s COVID-19 vaccine
The EU is making plans to buy 300 million doses of BioNTech-Pfizer’s COVID-19 vaccine.
The EU is making plans to buy 300 million doses of BioNTech-Pfizer’s COVID-19 vaccine.
On a W/W performance review, the Spanish Stock index, IBEX up 13.13%, and French Stock In CAC 40 up 12.59%
At about 10.05 am Nigerian time on Tuesday, November 10, Gold futures were up 1.69% at $1885.60.
Gold futures traded at $1,890/ounce, losing over 3% in value after trading as high as $1966/ounce on Monday morning.
Pfizer Inc could have a COVID-19 vaccine available in the world's largest economy by the end of 2020.
Pfizer Inc. has disclosed that its Covid-19 vaccine could be available for use in the U.S. by late November.
Moderna has already begun experimental testing on humans.
WHO has been working to expand access to potential vaccines and scale up production capacity.
UK now has 3 different types of vaccine under development with a total of 230 million doses.
BioNTech is in partnership with Pfizer to develop a coronavirus vaccine.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |